- Home
- IMCC vs SBFM Comparison
IMCC vs SBFM Comparison
Compare IMCC & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- SBFM
- Stock Information
- Founded
- IMCC 1980
- SBFM 2006
- Country
- IMCC Israel
- SBFM United States
- Employees
- IMCC N/A
- SBFM N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- SBFM Health Care
- Exchange
- IMCC Nasdaq
- SBFM Nasdaq
- Market Cap
- IMCC 5.0M
- SBFM 3.7M
- IPO Year
- IMCC N/A
- SBFM N/A
- Fundamental
- Price
- IMCC $2.23
- SBFM $3.14
- Analyst Decision
- IMCC
- SBFM
- Analyst Count
- IMCC 0
- SBFM 0
- Target Price
- IMCC N/A
- SBFM N/A
- AVG Volume (30 Days)
- IMCC 11.8K
- SBFM 90.8K
- Earning Date
- IMCC 11-11-2024
- SBFM 11-11-2024
- Dividend Yield
- IMCC N/A
- SBFM N/A
- EPS Growth
- IMCC N/A
- SBFM N/A
- EPS
- IMCC N/A
- SBFM N/A
- Revenue
- IMCC $36,445,402.00
- SBFM $30,481,982.00
- Revenue This Year
- IMCC $22.59
- SBFM $86.70
- Revenue Next Year
- IMCC $20.53
- SBFM $126.76
- P/E Ratio
- IMCC N/A
- SBFM N/A
- Revenue Growth
- IMCC N/A
- SBFM 109.82
- 52 Week Low
- IMCC $1.13
- SBFM $2.42
- 52 Week High
- IMCC $8.10
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- IMCC 41.06
- SBFM 52.62
- Support Level
- IMCC $2.02
- SBFM $2.85
- Resistance Level
- IMCC $2.15
- SBFM $3.05
- Average True Range (ATR)
- IMCC 0.14
- SBFM 0.14
- MACD
- IMCC -0.01
- SBFM 0.03
- Stochastic Oscillator
- IMCC 19.15
- SBFM 85.29
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.